Stay updated on Pembrolizumab for Hepatocellular Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Hepatocellular Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Hepatocellular Carcinoma Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    The page’s footer revision/version number was updated from v3.5.2 to v3.5.3, reflecting a minor site release rather than a change to the trial details.
    Difference
    0.1%
    Check dated 2026-04-24T16:44:40.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T13:41:32.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    The page revision label was updated to v3.5.0, replacing the previous v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-19T21:14:49.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    Revision tag on the site changed from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T20:13:29.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    Added the long-form study title for Pembrolizumab in HBV-related hepatocellular carcinoma and later removed an alternate title variant, with related regulatory notes.
    Difference
    0.6%
    Check dated 2026-03-05T17:59:45.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    Revision: v3.4.2 is now active, replacing v3.4.1. This update does not appear to change the study details or other critical information.
    Difference
    0.1%
    Check dated 2026-02-12T01:45:39.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Hepatocellular Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Hepatocellular Carcinoma Clinical Trial page.